Powder: | Yes |
---|---|
Customized: | Customized |
Certification: | GMP, HSE, USP, BP, SGS |
Suitable for: | Adult |
State: | Solid |
Purity: | >99% |
Samples: |
---|
Customization: |
---|
Suppliers with verified business licenses
Product Name | Vemurafenib |
|
|
Latin Name | N-(3-(5-(4-Chlorophenyl)-1H-pyrrolo[2,3-B]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonaMide | ||
CAS NO | 918504-65-1 | ||
MF | C23H18ClF2N3O3S | ||
MW | 489.92 | Density | 1.46 |
Assay | 99% | Form | White Powder |
Shelf life | 2 Years | Brand | Sonwu |
Vemurafenib is a low molecular weight orally absorbable BRAF serine-threonine kinase inhibitor that includes certain mutant forms of BRAFV600E.
Capecitabine | Everolimus | Afatinib | Vandetanib | Gefitinib |
Temozolomid | Rapamycin | Axitinib | Sorafenib tosylate | Cediranib |
Cabozantinib | Selumetinib | Crizotinib | Sunitinib malate | Erlotinib |
Crizotinib | Lapatinib | Debrafenib | Cabazitaxel | Ponatinib |
1. Customs clearance
Suppliers with verified business licenses